Table 1.
Sociodemographic characteristics and previous clinical history of patient's study.
| 2020 |
2021 |
|||||||
|---|---|---|---|---|---|---|---|---|
| Variables | Total (n = 425) | HIV infected (n = 86) | non-HIV infected (n = 339) | p-value | Total (n = 219) | HIV infected (n = 44) | non-HIV infected (n = 175) | p-value |
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |||
| Demographic data | ||||||||
| Age (years)a | 54.0 (43.0, 64.0) | 55.0 (47.0, 64.0) | 54.0 (43.0, 63.5) | 0.584 | 53.0 (46.0, 63.5) | 53.0 (44.0, 59.5) | 53.0 (46.0, 64.5) | 0.789 |
| Female | 252 (59.3%) | 54 (62.8%) | 198 (58.4%) | 0.538 | 119 (54.3%) | 26 (59.1%) | 93 (53.1%) | 0.590 |
| Lifestyle habits | ||||||||
| Current smoker | 27 (6.4%) | 11 (12.8%) | 16 (4.7%) | 0.013 | 13 (5.9%) | 6 (13.6%) | 7 (4.0%) | 0.027 |
| Previous smoker | 61 (14.4%) | 17 (19.8%) | 44 (13.0%) | 0.152 | 20 (9.1%) | 5 (11.4%) | 15 (8.6%) | 0.562 |
| Comorbidities | ||||||||
| Hypertension | 162 (38.1%) | 30 (34.9%) | 132 (38.9%) | 0.571 | 97 (44.3%) | 18 (40.9%) | 79 (45.1%) | 0.737 |
| Coronary artery disease | 19 (4.5%) | 7 (8.1%) | 12 (3.5%) | 0.079 | 7 (3.2%) | 1 (2.3%) | 6 (3.4%) | >0.999 |
| Heart failure | 21 (4.9%) | 5 (5.8%) | 16 (4.7%) | 0.780 | 7 (3.2%) | 2 (4.5%) | 5 (2.9%) | 0.630 |
| Atrial fibrillation/flutter | 9 (2.1%) | 2 (2.3%) | 7 (2.1%) | >0.999 | 2 (0.9%) | 0 (0.0%) | 2 (1.1%) | >0.999 |
| Stroke | 9 (2.1%) | 3 (3.5%) | 6 (1.8%) | 0.395 | 6 (2.7%) | 1 (2.3%) | 5 (2.9%) | >0.999 |
| Diabetes mellitus | 88 (20.7%) | 21 (24.4%) | 67 (19.8%) | 0.422 | 45 (20.5%) | 8 (18.2%) | 37 (21.1%) | 0.821 |
| Obesity | 62 (14.6%) | 5 (5.8%) | 57 (16.8%) | 0.016 | 44 (20.1%) | 8 (18.2%) | 36 (20.6%) | 0.886 |
| Asthma | 38 (8.9%) | 5 (5.8%) | 33 (9.7%) | 0.354 | 16 (7.3%) | 3 (6.8%) | 13 (7.4%) | >0.999 |
| Chronic obstructive pulmonary disease | 21 (4.9%) | 8 (9.3%) | 13 (3.8%) | 0.049 | 7 (3.2%) | 2 (4.5%) | 5 (2.9%) | 0.630 |
| Cancer | 37 (8.7%) | 13 (15.1%) | 24 (7.1%) | 0.032 | 6 (2.7%) | 3 (6.8%) | 3 (1.7%) | 0.097 |
| Cirrhosis | 3 (0.7) | 0 (0.0%) | 3 (0.9%) | >0.999 | 2 (0.9%) | 1 (2.3%) | 1 (0.6%) | 0.362 |
| Chronic kidney disease | 33 (7.8%) | 10 (11.6%) | 23 (6.8%) | 0.203 | 5 (2.3%) | 1 (2.3%) | 4 (2.3%) | >0.999 |
| Rheumatological disease | 7 (1.6%) | 1 (1.2%) | 6 (1.8%) | >0.999 | 4 (1.8%) | 1 (2.3%) | 3 (1.7%) | >0.999 |
| Psychiatric illness | 21 (4.9%) | 9 (10.5%) | 12 (3.5%) | 0.021 | 17 (7.8%) | 5 (11.4%) | 12 (6.9%) | 0.345 |
| Number of comorbidities | ||||||||
| 0 | 171 (40.2%) | 34 (39.5%) | 137 (40.4%) | 78 (35.6%) | 17 (38.6%) | 61 (34.9%) | ||
| 1 | 132 (31.1%) | 24 (27.9%) | 108 (31.9%) | 80 (36.5%) | 15 (34.1%) | 65 (37.1%) | ||
| 2 | 85 (20.0%) | 19 (22.1%) | 66 (19.5%) | 0.810 | 43 (19.6%) | 8 (18.2%) | 35 (20.0%) | 0.910 |
| 3 | 27 (6.4%) | 6 (7.0%) | 21 (6.2%) | 15 (6.8%) | 3 (6.8%) | 12 (6.9%) | ||
| 4 | 10 (2.3%) | 3 (0.7%) | 7 (1.6%) | 3 (1.4%) | 1 (2.3%) | 2 (1.1%) | ||
a
Median (Interquartile Range ‒ IQR). Statistical tests: Wilcoxon rank-sum test; Chi-Square test of independence; Fisher's exact test.